Fierce Biotech, a publication that monitors biotech news, has recognized thirteen prominent women in biotechnology for their contributions.
This year’s “Class of 2013” includes entrepreneurs running biotech companies, such as Narges Bani Asadi, co-founder and CEO of Bina Technologies, which is working towards making genomic data easier and faster to acquire so that doctors can better make decisions for their patients. The list also includes “key corporate players” such as Sue Dillon, Therapeutic Area Head in Immunology for Janssen Pharamceutica, who spearheads collaborations between Janssen and research and development firms. Other women, such as Katherin Jansen, who played a key role in developing the HPV vaccine Gardasil, are leading the industry in research and development. These three, and the ten other recognized women, each play an influential role in the biotech industry and offer a model for others—men and women alike—to follow.
In separate profiles, writers at Fierce Biotech describe the contributions that these women have made to the biotech industry, illustrating the talents required to succeed. The writers hope that the women will inspire others to pursue careers in biotechnology.
Read the full, original story here: Top women in biotech 2013
